Q3 2024 Cerus Corp Earnings Call Transcript

Oct 30, 2024 / 08:30 PM GMT

Release Date Price: $1.72 (+1.18%)

Transcript 10-Q8-K

Key Points

Positve

Cerus Corp (CERS) reported a strong quarterly performance with a 16% year-over-year growth in product revenue, driven by the North American platelet business.
The company raised its full-year 2024 product revenue guidance, reflecting positive trends in its business segments.
Cerus Corp (CERS) achieved a positive adjusted EBITDA of $4.4 million for Q3 2024, compared to a loss in the prior year period.
The INTERCEPT Fibrinogen Complex (IFC) business in the US is gaining momentum, with increased supply capacity and new BLA approvals.
The company is making significant progress in its international markets, with encouraging growth in key geographies and plans for further expansion.

Negative

Government contract revenue decreased to $4.6 million in Q3 2024 from $7.5 million in the prior year period, primarily due to the completion of the US Phase III ReCePI clinical trial.
The INTERCEPT RBC filing was not approved by the competent authority in Europe, leading to a reassessment of the strategy for future submissions.
Operating expenses for Q3 2024 included $5.8 million in non-cash, stock-based compensation, contributing to overall expenses.
The company faces ongoing challenges in navigating supply chain issues, although it has managed to mitigate customer impact.
Despite positive trends, the company remains cautious about potential variability in operating expenses and margins, maintaining a conservative outlook for the remainder of 2024.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CERS.OQ - Cerus Corp
Q3 2024 Cerus Corp Earnings Call
Oct 30, 2024 / 08:30PM GMT

=====================
Conference Call Participants
=====================
* Jessica Hanover
Cerus Corp - Vice President, Corporate Affairs
* William Greenman
Cerus Corp - President, Chief Executive Officer, Director
* Vivek Jayaraman
Cerus Corp - Chief Operating Officer
* Kevin Green
Cerus Corp - Chief Financial Officer, Vice President - Finance
* Ross Osborn
Cantor Fitzgerald - Analyst
* Matt Blackman
Stifel Nicolaus and Company, Incorporated - Analyst
* Jacob Johson
Stephens Inc. - Analyst
* Joshua Jennings
TD Cowen - Analyst
* Vidyun Bais
BTIG - Analyst
* Bill Bonello
Craig Hallum - Analyst

=====================
Presentation
--------------------------------------------------------------------------------
Operator [1]
------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.